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Abstract Sporadic inclusion body myositis (sIBM) is the
most common myopathy in people over the age of
50 years. While immune-mediated inﬂammatory myopa-
thies are well documented in dogs, sIBM has not been
described. An 11-year-old dog with chronic and progres-
sive neuromuscular dysfunction was evaluated for evidence
of sIBM using current pathologic, immunohistochemical
and electron microscopic diagnostic criteria. Vacuoles and
congophilic intracellular inclusions were identiﬁed in
cryostat sections of multiple muscle biopsies and immu-
nostained with antibodies against amyloid-b peptide,
amyloid-b precursor protein, and proteosome 20S of the
ubiquitin–proteosome system. Cellular inﬁltration and
increased expression of MHC Class I antigen were
observed. Cytoplasmic ﬁlamentous inclusions, membra-
nous structures, and myeloid bodies were identiﬁed
ultrastructurally. These observations constitute the ﬁrst
evidence that both the inﬂammatory and degenerative
features of human sIBM can occur in a non-human species.
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Introduction
The inﬂammatory myopathies (IMs) are a heterogeneous
group of diseases characterized by muscle degeneration
mediated by inﬂammatory and immune-mediated pro-
cesses. The most common IMs of humans are polymyositis
(PM), dermatomyositis (DM), and sporadic inclusion body
myositis (sIBM) [13, 16]. Other less common IMs of
humans include focal myositis, infectious myositis, mac-
rophagic myositis [11], and IM with abundant macrophages
[7]. There are many similarities between human and spon-
taneous canine IMs, including a broad spectrum of
underlying causes [41]. In dogs, the most frequently
reported IMs include the highly speciﬁc immune-mediated
masticatory muscle myositis [37, 42], polymyositis that
resembles PM of humans [18, 27, 41], and generalized
myositis from infectious causes [8, 14, 21, 31, 38]. Extra-
ocular myositis is a less commonly occurring focal
immune-mediated IM [1, 9]. Dermatomyositis, occurs in
certain breeds of dogs [23–25] and similar to human DM, is
associated with characteristic skin, muscle, and vascular
lesions. Although not yet fully characterized, IMs with
predominantly histiocytic cellular inﬁltration and similari-
ties to macrophagic myofascitis, and IM with abundant
macrophages have been identiﬁed in dogs (Shelton 2009,
unpublished observation).
Sporadic inclusion body myositis is the most common
progressive, degenerative and inﬂammatory myopathy in
humans over the age of 50 years [17, 34], and the most
debilitating muscle disease associated with aging [3, 4, 35].
Muscle weakness affects proximal muscles of the lower
limbs and distal muscles of the thoracic limbs [17]. In
contrast to patients with PM and DM, sIBM patients, as a
group, respond poorly to immunosuppressive therapies
suggesting that mechanisms other than an aberrant immune
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DOI 10.1007/s00401-009-0588-yresponse play a key role in sIBM pathogenesis [17]. Path-
ologically, sIBM is characterized by the presence of blue-
rimmed vacuoles in muscle ﬁbers that may have a central or
subsarcolemmal location, intracellular congophilic deposits
demonstrated by ﬂuorescence microscopy of Congo-red
stained muscle sections, ubiquitin positivity of the vacuoles,
typical ﬁlaments shown by electron microscopy, and
mononuclear cell inﬁltrations that may [32] or may not [10]
invade non-necrotic ﬁbers. While the exact pathogenesis of
sIBM remains unknown [22, 35], interactions between
aging, genetic and environmental factors are implicated. To
date, sIBM remains a poorly understood disease without
consistently beneﬁcial therapies [22]. Animal homologs are
widely regarded as valuable tools in the study of human
disease, yet an ideal animal model that accurately repro-
duces both the inﬂammatory and degenerative components
of sIBM does not exist [22, 35]. Here we describe, for the
ﬁrst time, a spontaneous vacuolar myopathy in an aged dog
with many similarities to human sIBM.
Case description
An 11-year-old male castrated, German shorthaired pointer
wasreferredtotheUniversityofCalifornia,Davis,Veterinary
MedicalTeachingHospital(UCD-VMTH)forevaluationofa
2-year history of chronic and progressive generalized weak-
ness and muscle atrophy, as well as increased respiratory
effort.Onphysicalandneurologicalexamination,generalized
atrophy of the limbs, trunk and head musculature was noted.
A short and choppy gait that progressed to collapse after
approximately 10–20 s of movement was observed. Pain
could not be elicited on palpation. Results of routine labora-
tory screening were within normal limits and serum creatine
kinase (CK) activity was not elevated. A generalized neuro-
muscular disease was suspected.
Materials and methods
Electrodiagnostic testing
Needle electromyography (EMG) was performed under
general inhalation anesthesia on numerous axial and
appendicular muscles. Motor and sensory nerve conduction
velocity (MNCV, SNCV) determinations were completed
on the right peroneal and ulnar nerves using established
techniques [36, 40, 43, 44].
Light microscopy
Biopsies from the vastus lateralis, triceps, and cranial
tibial muscles were collected under general inhalation
anesthesia. Specimens were ﬂash frozen in isopentane pre-
cooled in liquid nitrogen and stored at -80C until further
processed. Cryosections (8 lm) were evaluated by light
microscopy using a standard panel of histologic and his-
tochemical stains and reactions [15]. Congophilic deposits
were identiﬁed in Congo-red stained frozen sections with
ﬂuorescence microscopy using rhodamine optics [6] and
with crystal violet staining. Unﬁxed cryosections were
stained with monoclonal antibodies against b-amyloid
precursor protein (APP, Invitrogen, Carlsbad, CA) and
amyloid b peptide (Ab 1-42, Abcam, Cambridge, MA),
rabbit polyclonal antibody against proteosome 20S (Cal-
biochem, CA) and alpha sarcoglycan (a gift from Dr. E.
Engvall, The Burnham Institute for Medical Research, La
Jolla, CA, USA). Inﬁltrating cells were characterized in
unﬁxed cryosections using monoclonal antibodies against
canine CD4, CD8, CD11c, CD21 and MHC class II
antigens (Dr. Peter Moore, University of California,
Davis) and against MHC class I antigen (clone H58A,
VMRD, WA). Sections were further incubated with
afﬁnity-puriﬁed ﬂuorescein or rhodamine conjugated goat
anti-mouse or anti-rabbit IgG (H&L, Jackson Immuno-
Research Labs) prior to visualization with ﬂuorescence
microscopy.
Biopsies from the peroneal nerve also were collected
under general anesthesia. One portion of the biopsy was
frozen in isopentane pre-cooled in liquid nitrogen, while a
second portion was immersion ﬁxed in 2.5% glutaralde-
hyde in 0.1 M phosphate buffer, rinsed, then post-ﬁxed in
1% aqueous osmium tetroxide and embedded in araldite
resin as previously described [33].
Electron microscopy
Glutaraldehyde-ﬁxed muscle biopsy specimens were post-
ﬁxed in osmium tetroxide, and were dehydrated in serial
alcohol solutions and propylene oxide prior to embedding
in araldite resin. Thick sections (1 lm) were stained with
toluidine blue for light microscopy and ultrathin sections
(60–90 nm) were stained with uranyl acetate and lead cit-
rate for electron microscopy.
Results
Electrodiagnostic testing
Spontaneous activity, including prolonged insertional
activity, ﬁbrillation potentials, positive sharp waves, and
complex repetitive discharges, was detected in the majority
of muscles examined using EMG. Spontaneous activity
was mild and patchy (1?) in proximal limb muscles and
diffuse and moderate (2? to 3?) distally, with the thoracic
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123limb more severely affected than the pelvic limb. Motor
nerve conduction velocity (MNCV) for the right sciatic/
peroneal nerve was 56–57 m/s and for the right ulnar nerve
was 49 m/s suggestive of a mild motor neuropathy [43].
Sensory nerve conduction velocities (SNCV) for the right
sciatic/peroneal (53–60 m/s), ulnar (55 m/s) and radial
(58 m/s) nerves were within normal limits for this geriatric
dog [40]. Sensory nerve action potentials were robust for
the peroneal and radial nerves, but diminutive and dis-
persed for the ulnar nerve. Muscle and peripheral nerve
biopsies were collected from the dog’s left side.
Light and electron microscopy
The proximal limb muscles (vastus lateralis and triceps)
were more severely affected than the distal limb muscle
(cranial tibial). In the vastus lateralis and triceps muscles, a
marked variability in myoﬁber size was evident with
hypertrophic ﬁbers and atrophic ﬁbers having polygonal to
anguloid shapes (Fig. 1a), of both ﬁber types and with a
type 1 ﬁber predominance (not shown). Greater than 50%
of the myoﬁbers, predominately of type 1, contained var-
iably sized inclusions (Fig. 1a–d) and blue-rimmed (H&E)
or red-rimmed (modiﬁed Gomori trichrome stain) vacuoles
(Fig. 1c, d). Inclusions were positive with the Congo-red
(Fig. 1b, e) and crystal violet (not shown) stains, and were
labeled with monoclonal antibodies against amyloid pre-
cursor protein (Fig. 1f) and amyloid beta (Fig. 1g).
Accumulation of proteasomal subunits was identiﬁed with
an antibody against proteosome 20S (Fig. 1h) [19, 20].
Similar histochemical changes were observed in the triceps
muscle but to a lesser degree, while the cranial tibial
muscle was minimally affected (not shown). Pathologic
changes in the peroneal nerve biopsy were minimal (not
shown) and included small numbers of ﬁbers with myelin
splitting and ballooning, which may be an age-related
change [28, 29].
Multifocal areas of mild mononuclear cell inﬁltrations
were observed in the proximal limb muscles. Immuno-
phenotyping was performed on frozen vastus lateralis
muscle biopsy sections to determine inﬁltrating cell lin-
eages using established monoclonal antibodies to canine
lymphocyte antigens [39]. Inﬁltrating cells had an end-
omysial distribution with invasion of non-necrotic and
necrotic muscle ﬁbers (Fig. 2a). Cellular inﬁltrations
included CD4? (Fig. 2b) and CD8? (Fig. 2c) T lympho-
cytes, and rare CD21? B cells (Fig. 2d). Rare CD11C?
macrophage/dendritic cells were also observed (not
shown). MHC class I, present only on capillary endothelial
cells in normal muscle, was evident on inﬁltrating cells
with increased expression on the muscle sarcolemma
(Fig. 2e). Occasional MHC class II positive cells were also
observed (Fig. 2f).
Ultrastructural studies revealed membrane and non-
membrane bound subsarcolemmal inclusions that were
packed with randomly dispersed ﬁlaments (Fig. 3). Sub-
sarcolemmal ﬁlaments were oriented in different directions
and measured 12–17 nm in diameter (Fig. 3a, inset). It is
possible that the membrane bound inclusion in Fig. 3ai s
actually a nucleus, but a clear inner nuclear membrane was
not obvious. Filaments were often surrounded by glycogen
granules, irregular myeloid structures, disorganized myo-
ﬁbrils, degenerating mitochondria, and vacuoles. At higher
power, degenerating mitochondria (Fig. 3b) coalesced into
larger homogenous structures (Fig. 3c).
Fig. 1 Fresh frozen biopsy sections (8 lm) from the vastus lateralis
muscle were evaluated histologically (a, c, d), for Congo-red
localization (b, e) and by immunohistochemistry (f–h). Excessive
variability in myoﬁber size and shape, endomysial ﬁbrosis and
inclusions (arrows) were evident by light microscopy (a, H&E).
Inclusions were Congo-red positive by immunoﬂuorescence using
rhodamine optics (b, arrows). Prominent vacuoles were blue rimmed
with the H&E stain (c), red-rimmed with the modiﬁed Gomori
trichrome stain (d), and contained congo-red positive material (e).
Vacuoles stained positively with an antibody against amyloid
precursor protein (f) and with an antibody against amyloid beta (g).
Accumulation of proteasomal subunits were highlighted with an
antibody against proteosome 20S (h)
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Although sIBM is the inﬂammatory myopathy most fre-
quently recognized in humans over the age of 50 years and
the most important muscle disease associated with aging,
reports of sIBM in dogs do not exist, even though inﬂam-
matory myopathies are relatively common in this species.
The present report provides convincing histologic, immu-
nohistochemicaland ultrastructural evidence that a vacuolar
myopathy with many similarities to sIBM occurs in dogs.
While it is difﬁcult to extrapolate clinical features in
humans to dogs, many of the criteria for a diagnosis of
sIBM in humans were present in this case. The dog had a
chronic history of progressive muscle weakness and
wasting that primarily affected the proximal limb muscles.
Similarly, pathologic changes were more marked in prox-
imal than distal muscles. However, on EMG examination,
spontaneous activity was most pronounced in distal mus-
cles of the thoracic limb and interosseus muscles of both
the thoracic and pelvic limbs. This apparent difference may
be the result of sampling error, whereby EMG changes in
the larger proximal muscles were more focal in distribu-
tion, and thus more difﬁcult to appreciate. Alternatively,
proximal muscles may have been closer to end-stage.
Never the less, these ﬁndings are provocative given the
reports describing atrophy and weakness of the forearm
musculature in association with sIBM in people [2].
Quantitative EMG (qEMG), to determine whether the
EMG ﬁndings were myopathic or neuropathic in nature, is
not possible in dogs due to the need for volitional activity.
Human qEMG reports in sIBM are conﬂicting, with some
cases appearing myopathic, several labeled as neuropathic
and others having mixed results [2, 12, 26, 30]. In this case,
peroneal and ulnar MNCV examination revealed changes
suggestive of a mild motor neuropathy. As is the case in
humans, whether these changes are age-related or a feature
of sIBM in dogs is unclear. Similarly, the SNCV ﬁndings
were of interest. Of the three SNCV studies performed,
only the ulnar sensory nerve action potential was dispersed
and decreased in amplitude. Dabby [12] describes a subset
of 9 cases out of a group of 70 sIBM patients that were
originally diagnosed with motor neuron disease based on
clinical presentations and electrodiagnostic ﬁndings. In all
nine, both motor and sensory conduction velocities were
normal, but two had reduced CMAP.
As has been reported in a proportion of human sIBM
patients, serum CK activity was normal [10]. Muscle biopsy
features for deﬁnite sIBM in humans include the presence of
congophilic deposits within muscle ﬁbers, ﬁbers harboring
vacuoles rimmed by membranous material (rimmed vacu-
oles),and endomysialinﬂammatory exudateswith orwithout
invasion of necrotic or non-necrotic ﬁbers. Perivascular or
perimysial inﬂammation may or may not be present [10, 16].
In the present case, blue-rimmed vacuoles were apparent in
greater than 50% of the muscle ﬁbers that also contained
abnormal protein accumulations, including b-amyloid, and
increased proteasomal accumulations (Fig. 1). Further, im-
munophenotyping of cellular inﬁltrations demonstrated
CD8? T-cells with increased expression of MHC-I (Fig. 2).
Ultrastructural studies conﬁrmed the presence of randomly
dispersedﬁlamentousinclusions,disorganizedmyoﬁbrilsand
accumulation of degenerating organelles (Fig. 3).
Fig. 2 Fresh frozen sections (8 lm) from the vastus lateralis muscle
were evaluated histologically (a) and by immunoﬂuorescence for
identiﬁcation of inﬁltrating cells (b–d). Mononuclear cell inﬁltrations
had an endomysial distribution (a). Monoclonal antibodies against
canine leukocyte antigens (b–d), and for MHC I (e) and II (f) were
used. CD4? (b) and CD8? (c) T cells were predominant with rare
CD21? (d) cells and CD11c? macrophage/dendritic cells (not
shown). MHC I was evident on inﬁltrating cells and on the muscle
sarcolemma (e, arrow to sarcolemmal localization). Occasional MHC
II positive cells were also observed (f). The muscle sarcolemma was
identiﬁed by an antibody against a-sarcoglycan (red), nuclei were
localized by DAPI (blue) and inﬁltrating cells were identiﬁed by
ﬂuorescein conjugated secondary antibodies (green). Bar in
F = 50 lm for all immunoﬂuorescence ﬁgures
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123The mechanism of degenerative changes occurring in
muscle ﬁbers in sIBM remains poorly understood. Patho-
logically, sIBM is characterized by a unique combination of
changes comprising a predominantly T-cell inﬂammatory
inﬁltrate, muscle ﬁbers expressing MHC-1, and congophilic
inclusions and rimmed vacuoles containing b-amyloid
and a variety of other proteins. In addition, muscle ﬁbers
can show loss of cytochrome c oxidase activity, a
Fig. 3 Inclusions from the vastus lateralis muscle were evaluated
ultrastructurally. Both membrane and non-membrane bound inclu-
sions were evident (a) that were packed with randomly dispersed
ﬁlaments. Subsarcolemmal ﬁlaments were oriented in different
directions (a, inset) and measured 12–17 nm in diameter. Accumu-
lations of degenerating mitochondria (b) were evident at high power
that coalesced into larger homogenous structures (c). Bar 0.47 lm for
a, 0.27 lm for inset, 1.2 lm for b and 1.1 lm for c
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123mitochondrial-speciﬁc enzyme. Thus, it is still debated
whether sIBM is primarily a T-cell mediated inﬂammatory
myopathy or a myodegenerative disorder with abnormal
protein aggregation, inclusion body formation and a sec-
ondary inﬂammatory response in muscle. It is clear,
however, that intracellular accumulation of amyloid-b
precursor protein, amyloid-b, and amyloid-b oligomers in
the cellular milieu of an aging muscle is a key pathogenic
factor [4, 5].
In summary, much useful information can be gained
from animal models. Rodents provide important models for
studying molecular pathogenesis and the effects of gene
manipulations and cell transplantation. On the other hand,
larger animal homologs of human myopathies, such as the
dog, may provide more clinically relevant models. Cur-
rently available models of sIBM have not accurately
replicated the clinical and pathological aspects of human
sIBM. In fact, one recent literature review of sIBM [22]
suggests that most of the available animal models may be
ﬂawed and that their use could actually lead to clinical
studies in humans utilizing potentially harmful drugs. In
the present case, many of the clinical and pathological
aspects of human sIBM were fulﬁlled. While only one case
of a sIBM-like myopathy has been conﬁrmed in an aged
dog to date, it is possible that muscle wasting and weakness
in aged dogs is mistaken as arthritis or just a result of
aging, and appropriate diagnostic testing not performed.
Further study of naturally occurring canine sIBM-like
myopathies may provide valuable information on the
mechanism of degenerative and inﬂammatory changes in
aging IBM muscle. Factors that result in sIBM in people
may be similar to those resulting in sIBM-like myopathies
of older dogs. The identiﬁcation of sIBM-like changes in
our case is only a ﬁrst step. Based on this report, in-depth
studies of normal aging changes in canine muscle and in
dogs with chronic and progressive degenerative myopa-
thies are clearly necessary.
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